Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Kuros Biosciences AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Kuros Biosciences AG, Medical Devices Deals, 2012 to YTD 2018 10
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Kuros Biosurgery Raises Additional USD5 Million Financing 12
Kuros Biosurgery Raises USD15.34 Million in Venture Financing 13
Merger 14
Cytos Biotech Merges with Kuros Biosurgery 14
Licensing Agreements 15
Checkmate Pharma Amends Licensing Agreement with Kuros Biosciences 15
Cytos Biotechnology Enters into License Agreement with Novartis 16
Kuros Biosurgery Enters Into Licensing Agreement With Synthes 17
Equity Offering 18
Kuros Biosciences to Raise up to USD30.2 Million in Private Placement of Shares 18
Kuros Biosciences Raises Funds through Rights Offering of Shares 19
Kuros Biosciences Raises Funds through Public Offering of Shares 20
Cytos Biotechnology Completes Rights Offering Of Shares For US$26.7 Million 21
Cytos Biotechnology Completes Private Placement Of Shares For US$26 Million 22
Cytos Biotechnology Completes Rights Offering Of Shares For US$3.5 Million 24
Debt Offering 26
Cytos Biotechnology Announces Private Placement Of Secured Convertible Notes For US$14.5 Million 26
Kuros Biosciences AG – Key Competitors 28
Kuros Biosciences AG – Key Employees 29
Kuros Biosciences AG – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Sep 05, 2018: Kuros Biosciences announces results for first half 2018 31
Apr 30, 2018: Kuros Biosciences Reports Full-Year 2017 Results 32
Sep 26, 2017: Kuros Biosciences Reports Financial Results for First Half-Year of 2017 33
Apr 26, 2017: Kuros Biosciences Reports Financial Results for 2016 34
Corporate Communications 36
Aug 23, 2018: Kuros Biosciences names Pascal Longlade as chief medical officer 36
May 31, 2018: Kuros Biosciences to Propose Appointment of New Board Members at AGM 37
Dec 14, 2017: Kuros Biosciences Announces Management Succession 38
Nov 28, 2017: Kuros Biosciences’ Chief Medical Officer to Retire 39
Nov 16, 2017: Kuros announces management changes 40
Apr 28, 2017: Kuros Biosciences Proposes Election of Four New Board Members 41
Apr 13, 2017: Kuros announces CEO succession 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Kuros Biosciences AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Kuros Biosciences AG, Deals By Therapy Area, 2012 to YTD 2018 9
Kuros Biosciences AG, Medical Devices Deals, 2012 to YTD 2018 10
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Kuros Biosurgery Raises Additional USD5 Million Financing 12
Kuros Biosurgery Raises USD15.34 Million in Venture Financing 13
Cytos Biotech Merges with Kuros Biosurgery 14
Checkmate Pharma Amends Licensing Agreement with Kuros Biosciences 15
Cytos Biotechnology Enters into License Agreement with Novartis 16
Kuros Biosurgery Enters Into Licensing Agreement With Synthes 17
Kuros Biosciences to Raise up to USD30.2 Million in Private Placement of Shares 18
Kuros Biosciences Raises Funds through Rights Offering of Shares 19
Kuros Biosciences Raises Funds through Public Offering of Shares 20
Cytos Biotechnology Completes Rights Offering Of Shares For US$26.7 Million 21
Cytos Biotechnology Completes Private Placement Of Shares For US$26 Million 22
Cytos Biotechnology Completes Rights Offering Of Shares For US$3.5 Million 24
Cytos Biotechnology Announces Private Placement Of Secured Convertible Notes For US$14.5 Million 26
Kuros Biosciences AG, Key Competitors 28
Kuros Biosciences AG, Key Employees 29
Kuros Biosciences AG, Subsidiaries 30
List of Figures
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Kuros Biosciences AG, Medical Devices Deals, 2012 to YTD 2018 10